A blood based biomarker identifying early Alzheimer Disease's pathology

Project Information

VERDAD

Grant agreement ID: 849834

DOI 10.3030/849834

Project closed

EC signature date 24 May 2019

Start date 1 June 2019

End date 30 November 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 365 416,25

EU contribution € 2 355 791,00

Coordinated by

PRE DIAGNOSTICS AS
Norway

Deliverables

Demonstrators, pilots, prototypes (1)

Direct monocyte lysis and Aβ peptides recovery protocol

Websites, patent fillings, videos etc. (3)

Project website
Final project report

Final project report1PreDDECPUM30

Fully characterized mid domain beta Amyloid peptide mapping

Documents, reports (6)

Final protocol for large scale deployment of a fully automated method for Aβ peptides recovery from blood monocytes
Ethical approvals for the planned testing activities
Performance report from the in-vitro reference solutions tests
Societal demo activities report
CE-label documentation

CElabel documentation

Final automated immunoassay protocol

Open Research Data Pilot (1)

Performance report from the clinical blood samples

Intellectual Property Rights

Patent (2)

METHODS AND COMPOSITIONS FOR MONITORING PHAGOCYTIC ACTIVITY

Application/Publication number: 11 805939
Date: 2011-11-28

DIAGNOSTIC METHOD

Application/Publication number: 09 709860
Date: 2009-02-13